Search
Find a Doctor
Locations & Directions
Medical Services
Featured Medical Services
Cancer Care
Family Birthplace
Heart & Vascular
Mental Health
Neurology & Neurosurgery
Pediatrics
Rehabilitation
Women's Services
View All Services >
Quick Find Services
Emergency Care
Memorial Pembroke 24/7 Care Center
MemorialDOCNow
Patients & Visitors
Resources for Patients and Family Members
Visiting a Patient
Lodging and Family Support
Classes and Events Calendar
Billing and Insurance
Financial Assistance
Interpreter Services
International and Global Health
Quick Find Resources
Insurances Accepted
Pay My Bill
Healthcare Prices
About Memorial
The Memorial Experience
Our Approach to Care
History and Mission
Leadership and Governance
Financial Overview
Quality and Safety Data
Memorial Physician Group
Memorial Foundation
In the Community
Vendor Information
Newsroom
Healing the body, mind and spirit of those we touch.
Read Our Mission
toggle
Find a Doctor
Locations & Directions
Medical Services
Patients & Visitors
About Memorial
Log In To MyChart
Home
>
Clinical Trials
>
Clinical Trial Results
Return to Search
Clinical Trials Search Results
1
2
3
4
5
1 - 10 of 74 Results
A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients
This study is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent MRSA in patients with...
Read More
ALK Positive NSCLC - Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients
The purpose of this study has 2 phases, a Dose Finding Phase will determine the maximum tolerated dose.
Read More
ALK Positive NSCLC - Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Read More
Acute Lymphoblastic Leukemia - A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
This is a nonrandomized study of ruxolitinib in combination with a standard multi-agent chemotherapy regimen for the treatment of B-cell acute...
Read More
Acute Lymphoblastic Leukemia - Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Studies how well blinatumomab works compared with standard combination chemotherapy.
Status:
Accepting Participants
Read More
Acute Lymphoblastic Leukemia - Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
Compares how well combination chemotherapy works when given with or without bortezomib.
Status:
Accepting Participants
Read More
Acute Lymphoblastic Leukemia - Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia...
Read More
Acute Lymphoblastic Leukemia - Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Studies different combinations of risk-adapted chemotherapy regimens and their side effects.
Status:
Accepting Participants
Read More
Acute Lymphoblastic Leukemia - Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia.
Status:
Accepting Participants
Read More
Acute Myeloid Leukemia - Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Studies response-based chemotherapy in treating newly diagnosed acute myeloid leukemia.
Status:
Accepting Participants
Read More
1
2
3
4
5
1 - 10 of 74 Results
